Evidence Builds to Support Colchicine in Dealing with ASCVD

Evidence Builds to Support Colchicine in Dealing with ASCVD

NEW YORK — New insights into colchicine’s disruption of the pathway that contributes to arterial irritation and new clinical scientific studies of the drug could pave the way toward higher use of the anti-inflammatory drug in sufferers with or at possibility for atherosclerotic cardiovascular ailment (ASCVD), researchers explained at the 4th Once-a-year Cardiometabolic Risk in Inflammatory …
Read More

You May Also Like